ArticleRadiology2019
Diagnostic Accuracy of Multiparametric MRI versus
Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph
Article in Radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06494696 (Utilizing 68Ga-PSMA PET/MRI Imaging in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer Risk), which is not on this map. Cited by 64 papers, 8 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 8 pooled it
11.5field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Utilizing 68Ga-PSMA PET/MRI Imaging in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer Risk
Who cites it
64 citing papers in PubMed, 8 syntheses or guidelines pooled it, 120 citations in OpenAlex.
- Efficacy of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026Pooled it
- A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer.Prostate cancer and prostatic diseases · 2025Pooled it
- Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis.European radiology · 2024Pooled it
- Comparison ofFrontiers in oncology · 2024Pooled it
- The diagnostic accuracy of radiolabeled PSMA-ligand PET for tumour staging in newly diagnosed prostate cancer patients compared to histopathology: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2023Pooled it
- Pooled it
- The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature.European urology oncology · 2021Pooled it
- PET/MRI in prostate cancer: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2021Pooled it
- Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial.The Journal of urology · 2024Trial
- Head-to-Head Comparison ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Trial
- Head-to-head comparison of [¹⁸F]F-PSMA-1007 PET/CT and [⁶⁸Ga]Ga-PSMA-11 PET/CT for intraprostatic tumour detection and localisation using histopathology as reference: A prospective single-centre diagnostic accuracy study.European journal of nuclear medicine and molecular imaging · 2026Article
- External beam focal boost radiotherapy to intraprostatic lesions in prostate cancer: a scoping review.Physics and imaging in radiation oncology · 2026Review
- Development and validation of prostate-specific membrane antigen-adjusted Prostate Imaging Reporting and Data System: A new approach to enhancing the accuracy of diagnosing treatment-naïve primary prostate cancer.Asian journal of urology · 2026Article
- Integrating Multiparametric MRI and PSMA PET Imaging in Prostate Cancer: Toward a Unified Diagnostic and Risk-Stratification Paradigm.Medicina (Kaunas, Lithuania) · 2026Review
- Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomy.European journal of nuclear medicine and molecular imaging · 2026Article
- Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET/CT.Abdominal radiology (New York) · 2025Article
- Impact ofDiagnostics (Basel, Switzerland) · 2025Article
- Multimodal imaging deep learning model for predicting extraprostatic extension in prostate cancer using MpMRI and 18 F-PSMA-PET/CT.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025Article
- PSMA PET/CT for prostate cancer diagnosis: current applications and future directions.Journal of cancer research and clinical oncology · 2025Review
- Article
4 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
11 authors at 1 institution in 1 country.
Urs J MuehlematterFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).ORCID 0000-0003-3423-4633
Irene A BurgerFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Anton S BeckerFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).ORCID 0000-0001-8372-6496
Khoschy SchawkatFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Andreas M HötkerFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Cäcilia S ReinerFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Julian MüllerFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Niels J RuppFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).ORCID 0000-0002-7043-3456
Jan H RüschoffFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Daniel EberliFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Olivio F DonatiFrom the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).ORCID 0000-0003-4315-0984
University of Zurich · CH
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Recent studies have reported the additive value of combined gallium 68 (
Indexed as
Multimodal ImagingAgedEdetic AcidGallium IsotopesGallium RadioisotopesHumansMaleMiddle AgedMultiparametric Magnetic Resonance ImagingNeoplasm InvasivenessNeoplasm StagingOligopeptidesPositron-Emission TomographyProstatectomyProstatic NeoplasmsRadiopharmaceuticalsEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptidesRadiopharmaceuticals
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT06494696ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.